학술논문

Real-world use of ofatumumab to treat multiple sclerosis 9 months post-FDA approval during COVID-19 pandemic
Document Type
Article
Source
In: Multiple Sclerosis and Related Disorders. (Multiple Sclerosis and Related Disorders, October 2023, 78)
Subject
Language
English
ISSN
22110356
22110348